Home Pan Africa Mpox to Have Economic Consequences -Fitch Rating

Mpox to Have Economic Consequences -Fitch Rating

27
Mpox to Have Economic Consequences -Fitch Rating

(5 Minutes Read)

Supply chain disruptions could lead to a slowdown in economic growth. When raw materials cannot be transported from their source areas to factories, and finished goods cannot reach consumers, the entire production process grinds to a halt

The spread of Mpox in Africa, particularly in North Kivu, poses a severe threat to economic stability. With over 17,000 cases and 570 deaths reported this year in the DRC alone, the outbreak is alarming. The crisis has the potential to disrupt supply chains, strain tourism, and deter foreign investment, which are critical for economic growth and stability in the region.

Experts say the economic consequences of a continued spread of Mpox are dire. Supply chain disruptions could lead to a slowdown in economic growth. When raw materials cannot be transported from their source areas to factories, and finished goods cannot reach consumers, the entire production process grinds to a halt. This slowdown would result in high unemployment rates, compounding existing public debt challenges in many African countries.

Fitch Ratings-Hong Kong said that a potential acceleration in the spread of Mpox in sub-Saharan Africa (SSA) could raise the risk that the virus and efforts to curb its impact hurt economic activity and weaken fiscal metrics in affected sovereigns. Any fiscal impact under such a scenario would probably be partially offset by additional financing from donors and official and multilateral partners.

The World Health Organisation declared the upsurge of Mpox in the Democratic Republic of Congo (DRC) and a growing number of African countries a public health emergency of international concern on 14 August. Several Fitch-rated SSA sovereigns reported confirmed Mpox cases in July-August, including Cote d’Ivoire (BB-/Stable), Kenya (B-/Stable), Rwanda (B+/Stable), South Africa (BB-/Stable) and Uganda (B+/Negative).

In most of these, the number of confirmed Mpox cases is very low, often in the single digits. However, there could be underreporting in some countries and the emergency declaration highlights the potential for case numbers to rise sharply, bringing the prospect of financial pressure for affected sovereigns.

Virus outbreaks can have significant economic and fiscal effects, as was demonstrated by the Covid-19 pandemic and the 2014-2015 Ebola epidemic in West Africa. The latter shock resulted in sharply lower economic growth and a widening of budget deficits in the main affected countries, Liberia, Guinea and Sierra Leone, although it is difficult to disaggregate the effects of Ebola from those of the concurrent fall in commodity prices.

Past outbreaks are also an imperfect guide to future risks, the rating agency said.  For example, Mpox has so far had a significantly lower fatality rate than Ebola, which means economic activity may be less directly affected. Some vaccines are available to be deployed against Mpox, though at present access to these vaccines remains relatively limited in SSA. A previous public health emergency of international concern over a global Mpox outbreak, lasting from July 2022 to May 2023, did not significantly impact key credit metrics for affected sovereigns.

In the event of a substantial increase in Mpox case counts, the main impact on economies from the virus and the measures to counter it would likely be on consumption and production. Tourism could be hit – a potentially significant factor in Kenya, Rwanda and Uganda – where UN Tourism data indicate tourism accounted for 11%, 20%, and 19%, respectively, of total goods and services export earnings in 2022. There could also be challenges managing inflationary effects, especially if food production and/or logistics are significantly disrupted.

Read Also:

https://trendsnafrica.com/nigeria-becomes-first-country-to-get-mpox-vaccines/

Fiscal metrics would also be affected, with weaker economic activity depressing tax revenues, and higher government spending on healthcare and epidemic-prevention measures. International assistance could mitigate these effects, but its timing and size is uncertain. The World Bank has estimated that over 2014-2015 grants reached nearly 19% of GDP in Liberia, almost 10% of GDP in Sierra Leone, and about 5% in Guinea.